Skip to main content

UBS Group AG

Position in LGVN — Longeveron Inc.

CIK 1610520 ZURICH, V8

Position in LGVN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3
-$15,453 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 39 holders
Holding Since
Mar 2021
18 quarters on record

Common Shares in LGVN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. LGVN ranks #550 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LGVN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3 5
2026-03-31 $15,456 14,862
2025-12-31 $30,465 60,208
2025-09-30 $47,992 63,982
2025-06-30 $109,375 84,135
2025-03-31 $85,659 55,264
2024-12-31 $1,752 1,013
2024-09-30 $1,196 617
2024-06-30 $1 1
2024-03-31 $39 12
2023-12-31 $2,381 1,751
2023-06-30 $436 129
2023-03-31 $11,769 4,408
2022-12-31 $11,279 3,503
2022-06-30 $3,024 510
2021-09-30 $34,004 9,633
2021-06-30 $20,999 2,583
2021-03-31 $12,323 1,870